首页 > 抗体蛋白 > 抗体
PerCP/Cyanine5.5 anti-mouse CD11c Antibody
产品名称:
PerCP/Cyanine5.5 anti-mouse CD11c Antibody
产品类别:
抗体
产品编号:
117327
产品应用:
117327
[价格]
规格 价格 库存
25µg ¥ 1416 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor? 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  24. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Kitagawa S, et al. 2022. NPJ Vaccines. 7:115. PubMed
  2. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  3. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  4. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  5. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  6. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  7. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  8. Peters N, et al. 2012. J Immunol. 189:4832. PubMed
  9. Zas?ona Z, et al. 2014. J Immunol. 193:4245. PubMed
  10. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  11. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  12. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  13. Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed
  14. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  15. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  16. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  17. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  18. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  19. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  20. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  21. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  22. Rodriguez AB, et al. 2021. Cell Reports. 36(3):109422. PubMed
  23. Blijswijk J, et al. 2015. J Immunol. 194:307. PubMed
  24. Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
  25. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  26. Speth JM, et al. 2019. JCI Insight. 4:e131340. PubMed
  27. Bennion BG, et al. 2020. Cell Reports. 31(11):107771. PubMed
  28. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  29. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  30. Liang Y, et al. 2014. J Immunol. 192:1277. PubMed
  31. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  32. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  33. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  34. Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
  35. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  36. Ma W, et al. 2017. Sci Rep. . 10.1038/s41598-017-15661-6. PubMed
  37. Guo L, et al. 2021. Vaccines (Basel). 9:. PubMed
  38. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  39. Roberts LM, et al. 2021. iScience. 24:103025. PubMed
  40. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  41. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  42. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  43. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  44. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  45. Bastow CR, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  46. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  47. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  48. Chatterjee D, et al. 2021. Cell Reports. 35(2):108996. PubMed
  49. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  50. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  51. Poczobutt J, et al. 2016. J Immunol. 196: 2847 - 2859. PubMed
  52. Steiger S, et al. 2015. J Immunol. 195: 5495 - 5502. PubMed
  53. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  54. Luo J et al. 2018. Immunity. 49(1):107-119 . PubMed
  55. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  56. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  57. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  58. Ahn D, et al. 2021. Cell Reports. 35(9):109196. PubMed
  59. Zasłona Z, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L855. PubMed
  60. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  61. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  62. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  63. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  64. Hofmann J, et al. 2021. Front Immunol. 11:599495. PubMed
  65. Peters N, et al. 2009. PLoS One. 5:e1000484. PubMed
  66. Kitur K, et al. 2015. PLoS Pathog. 11:1004820. PubMed
  67. Xu J, et al. 2020. Immunity. 53(2):371-383.e5. PubMed
  68. Isvoranu G, et al. 2019. Oncol Lett. 17:4197. PubMed
  69. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  70. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  71. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  72. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  73. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  74. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  75. Ren S, et al. 2022. Int J Biol Sci. 18:166. PubMed
  76. Dhayade S, et al. 2020. Nutrients. 12:. PubMed
  77. Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
  78. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  79. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  80. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  81. Sakamoto K, et al. 2022. STAR Protoc. 3:101052. PubMed
  82. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  83. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  84. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  85. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  86. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  87. Samuelson DR, et al. 2021. Commun Biol. 4:997. PubMed
  88. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  89. Spanier J, et al. 2016. Nat Commun. 7:11804. PubMed
  90. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
RRID
AB_2129642 (BioLegend Cat. No. 117327) AB_2129641 (BioLegend Cat. No. 117328)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线